Bumrungrad Hospital Public Company Limited
BH.BK

$6.59 B
Marketcap
$8.30
Share price
Country
$0.03
Change (1 day)
$8.57
Year High
$6.40
Year Low

Bumrungrad Hospital Public Company Limited owns and operates healthcare-related entities in Thailand and internationally. The company offers diagnostic, therapeutic, and intensive care facilities in a medical center. Its outpatient clinics/centers include allergy, arrhythmia, behavioral health, breastfeeding, breast care, children, dental, diabetes, diagnostic, dialysis, digestive disease, emergency, eye, fertility and IVF, health screening, hearing and balance, heart valve, cancer, hyperbaric oxygen therapy, hypertension, joint replacement, liver, memory, men, nephrology, neuroscience, new life healthy aging, orthopedic, Parkinson's disease and movement disorders, perinatal, physical therapy and rehabilitation, plastic surgery, pulmonary, refractive surgery, robotic scoliosis and surgery, skin, sleep lab, spine, sports medicine and lifestyle, surgical, travel medicine, urology, vitalife, and women's, as well as ear, nose, and throat centers. In addition, the company is involved in the real estate assets holding activities; provision of clinical research services; distribution of pharmaceutical and medical goods in specialized stores; operation of personnel development and training center for healthcare services; and patient referral service business. It operates 580 beds and approximately 56 clinics/centers. The company was founded in 1980 and is headquartered in Bangkok, Thailand.

marketcap

Revenue of Bumrungrad Hospital Public Company Limited (BH.BK)

Revenue in 2023 (TTM): $763.29 M

According to Bumrungrad Hospital Public Company Limited's latest financial reports the company's current revenue (TTM) is $763.29 M. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history of Bumrungrad Hospital Public Company Limited

Annual Revenue

Year Revenue Gross Profit Ebitda Income Before Tax Net Income
2023 $763.29 M $365.51 M $281.16 M $260.66 M $211.41 M
2022 $625.23 M $290.32 M $216.43 M $182.52 M $149.01 M
2021 $375.98 M $142.71 M $84.91 M $43.93 M $36.68 M
2020 $373.02 M $141.36 M $81.89 M $41.37 M $36.33 M
2019 $557.45 M $247.1 M $178.1 M $136.8 M $113.09 M
2018 $552.97 M $249.84 M $192.7 M $151.97 M $125.28 M
2017 $553.59 M $237.97 M $185.49 M $144.3 M $119 M
2016 $540.56 M $226.75 M $172.27 M $132.1 M $109.42 M
2015 $532.89 M $219.2 M $164.03 M $128.27 M $103.67 M
2014 $471.62 M $185.09 M $138.95 M $103.2 M $82.38 M
2013 $432.88 M $166.26 M $124.38 M $94.93 M $76.06 M
2012 $391.74 M $143.34 M $104.03 M $101.3 M $80.47 M
2011 $332.36 M $133.25 M $78.07 M $63.19 M $47.92 M
2010 $303.82 M $124.48 M $73.32 M $53.28 M $37.97 M
2009 $281.76 M $114.2 M $69.6 M $51 M $37.59 M
2008 $268 M $107.34 M $65.22 M $49.21 M $35.94 M
2007 $284.03 M $129.54 M $80.79 M $65.15 M $48.44 M
2006 $238.24 M $94.16 M $62.5 M $48.86 M $33.06 M
2005 $205.39 M $80.3 M $53.42 M $41.39 M $31.77 M
2004 $175.29 M $64.76 M $44.92 M $33.99 M $28.2 M
2003 $139.41 M $50.72 M $35.23 M $24.25 M $20.11 M